Taherkhani Reza, Farshadpour Fatemeh, Makvandi Manoochehr, Rajabi Memari Hamid, Samarbafzadeh Ali Reza, Sharifi Nasrin, Naeimi Behrouz, Tajbakhsh Saeed, Akbarzadeh Samad
Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran ; Persian Gulf Tropical Medicine Research Centre, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran.
Health Research Institute, Infectious and Tropical Disease Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.
J Trop Med. 2015;2015:523560. doi: 10.1155/2015/523560. Epub 2015 Sep 15.
Background. The aim of this study was to evaluate hepatitis E virus (HEV) specific cellular immune responses to truncated ORF2 protein in Iranian patients recovered from HEV infection. Information about HEV-specific immune responses could be useful in finding an effective way for development of HEV vaccine. Methods. A truncated form of HEV ORF2 protein containing amino acids 112-608 was used to stimulate peripheral blood mononuclear cells (PBMCs) separated from HEV-recovered and control groups. Finally, the levels of four cytokines, IFN-γ ELISPOT, and cell proliferative responses following stimulation with the truncated ORF2 protein were assessed in the both groups. Results. The truncated ORF2 protein was able to induce IFN-γ ELISPOT and cell proliferation responses and to produce significant amounts of IFN-γ and IL-12 cytokines, but low amounts of IL-10 and IL-4 cytokines in vitro. These responses were significantly higher in the recovered group compared to the control group. These results indicate the antigenic nature of the truncated ORF2 protein and production of T helper type 1 cytokines. Conclusion. The truncated ORF2 protein can effectively induce significant cellular immune responsesand can be introduced as a potential vaccine candidate. However, further studies are required to evaluate this protein in vivo.
背景。本研究旨在评估伊朗戊型肝炎病毒(HEV)感染康复患者对截短的ORF2蛋白的特异性细胞免疫反应。有关HEV特异性免疫反应的信息可能有助于找到开发HEV疫苗的有效方法。方法。使用包含氨基酸112 - 608的截短形式的HEV ORF2蛋白刺激从HEV康复组和对照组分离的外周血单个核细胞(PBMC)。最后,在两组中评估用截短的ORF2蛋白刺激后四种细胞因子、IFN-γ ELISPOT和细胞增殖反应的水平。结果。截短的ORF2蛋白能够在体外诱导IFN-γ ELISPOT和细胞增殖反应,并产生大量的IFN-γ和IL-12细胞因子,但产生少量的IL-10和IL-4细胞因子。与对照组相比,康复组的这些反应明显更高。这些结果表明截短的ORF2蛋白的抗原性质以及1型辅助性T细胞因子的产生。结论。截短的ORF2蛋白可有效诱导显著的细胞免疫反应,并可作为潜在的疫苗候选物引入。然而,需要进一步的研究来在体内评估该蛋白。